Featured Share Your Research

Merel l'Ami

Merel l'Ami is a research scientist at Amsterdam Rheumatology and immunology Center, Reade, 1056 AB Amsterdam, Netherlands.

TNF Concentrations During TNF Inhibitor Treatment Predict Anti-drug Antibody Formation

TNF is an important mediator that drives the pathogenesis of several inflammatory auto-immune diseases, including Crohn’s Disease and rheumatoid arthritis (RA). Treatment of these diseases has significantly improved since the introduction of therapeutic monoclonal antibodies that specifically target TNF (TNF […]